ArticleCancer medicine2024

Evaluation of the association between predictive factors and the development of immune-related adverse events and prognostic factors for chemoimmunotherapy in patients with non-small cell lung cancer: A multicenter retrospective study.

Ryota Ozawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.